DNA hypomethylating agents 5-aza-2'-deoxycytidine and valproate increase neuronal 5-lipoxygenase mRNA

Eur J Pharmacol. 2002 Jun 7;445(1-2):149-50. doi: 10.1016/s0014-2999(02)01711-9.

Abstract

DNA methylation regulates gene expression. Neuronal 5-lipoxygenase expression increases during aging and during the proliferation of immature rat cerebellar granule neurons. In these cultures, we investigated the effects of hypomethylating agents 5-aza-2'-deoxycytidine (AdC) and valproate on 5-lipoxygenase mRNA. Both drugs increased 5-lipoxygenase mRNA in proliferating cells; only valproate was effective in differentiated neurons. We propose that neuronal 5-lipoxygenase expression can be affected by aging-altered DNA methylation and by hypomethylating drugs, such as the anticonvulsant valproate.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Arachidonate 5-Lipoxygenase / biosynthesis*
  • Azacitidine / analogs & derivatives*
  • Azacitidine / pharmacology*
  • Cells, Cultured
  • Cerebellum
  • DNA Methylation / drug effects*
  • Decitabine
  • Neurons / drug effects*
  • Neurons / enzymology
  • RNA, Messenger / biosynthesis*
  • Rats
  • Valproic Acid / pharmacology*

Substances

  • RNA, Messenger
  • Valproic Acid
  • Decitabine
  • Arachidonate 5-Lipoxygenase
  • Azacitidine